Full metadata record
DC FieldValueLanguage
dc.contributor.authorLawung, Ratana-
dc.contributor.authorCherdtrakulkiat, Rungrot-
dc.contributor.authorNabu, Sunanta-
dc.contributor.authorPrachayasittikul, Supaluk-
dc.contributor.authorIsarankura-Na-Ayudhya, Chartchalerm-
dc.contributor.authorPrachayasittikul, Virapong-
dc.date.accessioned2019-02-01T12:05:16Z-
dc.date.available2019-02-01T12:05:16Z-
dc.date.issued2018-08-23-
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/37896-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-19883-
dc.description.abstractThe multidrug resistance of Neisseria gonorrhoeae becomes a public health problem worldwide, especially the strain H041 that showed the decrease susceptibility to ceftriaxone which is the last resort for gonorrhea treat- ment. Therefore, the simultaneous discovery and development of a new compound to fight this pathogen is ur- gently required. In this study, 8-hydroxyquinoline (8HQ) and derivatives were evaluated for their antimicrobial activities against the gonococcal pathogen using spectinomycin as the reference drug. The results showed that 8HQ derivatives gave an excellent antimicrobial potency. Particularly, the dihalogenated 8HQ (iodoquinol, clio- quinol and 5,7-diCl-8HQ) exerted the high activity with MIC range of 0.08-0.15 µM, 0.10-0.20 µM and 0.28- 0.56 µM, respectively, compared with the reference drug (MIC = 16 µg/mL or 48.14 µM). Moreover, these compounds were also shown to be non-cytotoxic/very high safety index. The findings reveal that these three compounds could be further developed as a new antimicrobial agent for fighting the gonorrheal disease.en
dc.language.isoen-
dc.relation.ispartofseriesEXCLI Journal;Vol. 17 2018-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectNeisseria gonorrhoeaeen
dc.subjectAntimicrobial resistanceen
dc.subjectAntibacterial activityen
dc.subject8-hydroxyquinoline and derivativesen
dc.subject.ddc610-
dc.titleRepositioning of 8-hydroxyquinoline derivatives as a new promising candidate for combating multidrug resistant Neisseria gonorrhoeaeen
dc.typeText-
dc.type.publicationtypearticle-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.secondarypublicationtrue-
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Prachayasittikul_23082018_proof.pdfDNB167.94 kBAdobe PDFView/Open


This item is protected by original copyright



All resources in the repository are protected by copyright.